Literature DB >> 10516039

Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats.

D S Steinwaerder1, C A Carlson, A Lieber.   

Abstract

Direct or inverse repeated sequences are important functional features of prokaryotic and eukaryotic genomes. Considering the unique mechanism, involving single-stranded genomic intermediates, by which adenovirus (Ad) replicates its genome, we investigated whether repetitive homologous sequences inserted into E1-deleted adenoviral vectors would affect replication of viral DNA. In these studies we found that inverted repeats (IRs) inserted into the E1 region could mediate predictable genomic rearrangements, resulting in vector genomes devoid of all viral genes. These genomes (termed DeltaAd.IR) contained only the transgene cassette flanked on both sides by precisely duplicated IRs, Ad packaging signals, and Ad inverted terminal repeat sequences. Generation of DeltaAd.IR genomes could also be achieved by coinfecting two viruses, each providing one inverse homology element. The formation of DeltaAd.IR genomes required Ad DNA replication and appeared to involve recombination between the homologous inverted sequences. The formation of DeltaAd. IR genomes did not depend on the sequence within or adjacent to the inverted repeat elements. The small DeltaAd.IR vector genomes were efficiently packaged into functional Ad particles. All functions for DeltaAd.IR replication and packaging were provided by the full-length genome amplified in the same cell. DeltaAd.IR vectors were produced at a yield of approximately 10(4) particles per cell, which could be separated from virions with full-length genomes based on their lighter buoyant density. DeltaAd.IR vectors infected cultured cells with the same efficiency as first-generation vectors; however, transgene expression was only transient due to the instability of deleted genomes within transduced cells. The finding that IRs present within Ad vector genomes can mediate precise genetic rearrangements has important implications for the development of new vectors for gene therapy approaches.

Mesh:

Substances:

Year:  1999        PMID: 10516039      PMCID: PMC112965     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.

Authors:  A Lieber; C Y He; L Meuse; D Schowalter; I Kirillova; B Winther; M A Kay
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication.

Authors:  J E Nelson; M A Kay
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1.

Authors:  J K Kim; C Palaniappan; W Wu; P J Fay; R A Bambara
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

Review 4.  Biochemistry of genetic recombination: energetics and mechanism of DNA strand exchange.

Authors:  S C Kowalczykowski
Journal:  Annu Rev Biophys Biophys Chem       Date:  1991

5.  Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo.

Authors:  A Lieber; C Y He; M A Kay
Journal:  Nat Biotechnol       Date:  1997-12       Impact factor: 54.908

6.  A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging.

Authors:  R J Parks; F L Graham
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Characterization of the chicken beta-globin insulator.

Authors:  J H Chung; A C Bell; G Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

8.  Sequence-specific pausing during in vitro DNA replication on double-stranded DNA templates.

Authors:  P Bedinger; M Munn; B M Alberts
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

9.  Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy.

Authors:  M A Hauser; A Amalfitano; R Kumar-Singh; S D Hauschka; J S Chamberlain
Journal:  Neuromuscul Disord       Date:  1997-07       Impact factor: 4.296

10.  SK HEP-1: a human cell line of endothelial origin.

Authors:  S C Heffelfinger; H H Hawkins; J Barrish; L Taylor; G J Darlington
Journal:  In Vitro Cell Dev Biol       Date:  1992-02
View more
  13 in total

1.  Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.

Authors:  A Lieber; D S Steinwaerder; C A Carlson; M A Kay
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.

Authors:  D M Shayakhmetov; T Papayannopoulou; G Stamatoyannopoulos; A Lieber
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.

Authors:  Pete Murakami; Menzo Havenga; Farah Fawaz; Ronald Vogels; Giuseppe Marzio; Erno Pungor; Jim Files; Linh Do; Jaap Goudsmit; Michael McCaman
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner.

Authors:  Dmitry M Shayakhmetov; Zong-Yi Li; Anuj Gaggar; Helen Gharwan; Vladimir Ternovoi; Volker Sandig; André Lieber
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Adeno-associated virus (AAV) Rep protein enhances the generation of a recombinant mini-adenovirus (Ad) utilizing an Ad/AAV hybrid virus.

Authors:  Z Sandalon; D V Gnatenko; W F Bahou; P Hearing
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.

Authors:  Dmitry M Shayakhmetov; Cheryl A Carlson; Hartmut Stecher; Qiliang Li; George Stamatoyannopoulos; André Lieber
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 7.  Conditionally replicating adenoviruses for cancer treatment.

Authors:  Youssef Jounaidi; Joshua C Doloff; David J Waxman
Journal:  Curr Cancer Drug Targets       Date:  2007-05       Impact factor: 3.428

Review 8.  Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.

Authors:  Julia Fakhiri; Dirk Grimm
Journal:  Mol Ther       Date:  2021-04-05       Impact factor: 11.454

9.  Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells.

Authors:  Maarten Holkers; Ignazio Maggio; Jin Liu; Josephine M Janssen; Francesca Miselli; Claudio Mussolino; Alessandra Recchia; Toni Cathomen; Manuel A F V Gonçalves
Journal:  Nucleic Acids Res       Date:  2012-12-28       Impact factor: 16.971

10.  Targeted chromosomal insertion of large DNA into the human genome by a fiber-modified high-capacity adenovirus-based vector system.

Authors:  Manuel A F V Gonçalves; Maarten Holkers; Gijsbert P van Nierop; Roeland Wieringa; Maria G Pau; Antoine A F de Vries
Journal:  PLoS One       Date:  2008-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.